NCT03358485View on ClinicalTrials.gov

Study of Aolanti Weikang Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

April 21, 2018

Study Completion Date

June 30, 2018

Conditions
Functional Dyspepsia
Interventions
DRUG

Aolanti Weikang tablets

Aolanti Weikang tablets is a Chinese patent drug designed to treat Functional dyspepsia (FD).

OTHER

Placebo

Placebo

Trial Locations (1)

100091

Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing

Sponsors
All Listed Sponsors
lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY